Sodium cromoglycate and ipratropium bromide in exercise-induced asthma - Wikidata - awgldk - TriplyDB

Sodium cromoglycate and ipratropium bromide in exercise-induced asthma

Sodium cromoglycate and ipratropium bromide in exercise-induced asthma

http://www.wikidata.org/entity/Q36453616

about

Mast-cell stabilising agents to prevent exercise-induced bronchoconstriction Anticholinergic therapy for chronic asthma in children over two years of age Calcium antagonists in exercise-induced asthma Bronchodilator effects of clemastine, ipratropium, bromide, and salbutamol in preschool children with asthma Dose-response study of sodium cromoglycate in exercise-induced asthma.Effect of lignocaine, sodium cromoglycate, and ipratropium bromide in exercise-induced asthma.Dual effect of prostaglandin E2 on normal airways smooth muscle in vivo.The bronchial response to cold air challenge: evidence for different mechanisms in normal and asthmatic subjects.Effect of an inhaled antihistamine on exercise-induced asthma.Cholinergic blockade in the prevention of exercise-induced asthma.Reproducibility of flow rates measured with low density gas mixtures in exercise-induced bronchospasm.Asthma in children and adolescents: a comprehensive approach to diagnosis and management.Hyperventilation-induced asthma: evidence for two mechanisms.Loop diuretics inhibit cholinergic and noncholinergic nerves in guinea pig airways.Lack of correlation between the grade of methacholine-induced bronchial hyperreactivity and ipratropium bronchodilation in asthmatics.

P2860

Q24247733-32F33A63-0808-463B-BC4D-022E9E566506 Q24247918-A946806C-9E92-46F8-942A-F0B55F8165AB Q34778321-2B920990-C44B-4F90-AC78-115595232A3D Q35115528-14D1F4C3-96ED-449D-9947-F6843E21C711 Q36123441-B678696D-A32F-49F1-9AC2-D2DB30ABCE0C Q36123913-F58D0E48-0E40-4339-8FA2-9E1EE6FF9E85 Q36125081-40B1616F-9D3B-4411-87B0-77BC8FCFD65D Q36129529-3F1641F9-2BB8-4CD6-B981-2917C8E1E9F9 Q36464672-58800014-CC09-4E2F-A285-A8E0475A9D0A Q36464713-D8DBEF56-7F6C-4F83-881F-D7B5874DF0C9 Q36478211-DDC2C993-2F2D-46BD-9BF7-0325F7D3795E Q37970318-366E11D7-26D6-45A5-8D99-6A590E168B78 Q41119484-0292FAAD-BDAD-4580-9C6E-7B4C3CF03E52 Q53859144-F6DCD1DD-FB3E-4D58-AD41-F15CF69BF851 Q54394399-0FD67ED4-9EDB-4FAB-A999-E93310934093

P2860

Sodium cromoglycate and ipratropium bromide in exercise-induced asthma

http://www.wikidata.org/entity/Q36453616

description

1978 nî lūn-bûn

@nan

1978年の論文

@ja

1978年学术文章

@wuu

1978年学术文章

@zh-cn

1978年学术文章

@zh-hans

1978年学术文章

@zh-my

1978年学术文章

@zh-sg

1978年學術文章

@yue

1978年學術文章

@zh

1978年學術文章

@zh-hant

name

Sodium cromoglycate and ipratropium bromide in exercise-induced asthma

@ast

Sodium cromoglycate and ipratropium bromide in exercise-induced asthma

@en

type

label

Sodium cromoglycate and ipratropium bromide in exercise-induced asthma

@ast

Sodium cromoglycate and ipratropium bromide in exercise-induced asthma

@en

prefLabel

Sodium cromoglycate and ipratropium bromide in exercise-induced asthma

@ast

Sodium cromoglycate and ipratropium bromide in exercise-induced asthma

@en

P1433

Q36453616-0CFA3BDC-4E0E-40B5-B608-2B012046FF65

P1476

Q36453616-5EB8C0A0-47CE-4738-A440-92E66D8902DB

P2093

Q36453616-89BB16C3-5336-4F31-8C6F-45A64EA47261

Q36453616-9D2AC877-A839-4678-AF30-2ACB5859842C

Q36453616-D182C6D3-6567-450C-8BE7-AC562D2BEC4D

P2860

Q36453616-1BB07E6D-1D6E-4813-99A4-E0B0334D2E02

Q36453616-62EBE1C1-F9E0-4CDD-A69F-88968676A897

Q36453616-7F21CED9-51AA-4A0C-81E2-8D35B516F590

Q36453616-84B1E9F9-0EDA-433E-9AA2-619FA1242E32

Q36453616-86400175-B391-43B0-84D2-09545496475A

Q36453616-97E0F312-727C-4324-A18B-55237CC4565D

Q36453616-A6B98245-7B84-4D4D-9BEA-67B97481DCFC

Q36453616-CFA09AB4-053F-4CE6-9ECE-B6FC6F1FF3BA

Q36453616-D2F97C39-EE2D-4C04-8BE8-B94241719471

Q36453616-D69135E5-CE24-41B1-865D-8564BEB1FC86

P304

Q36453616-574E88F5-459A-41D7-8870-AC6A020BE9D1

P31

Q36453616-FDD62FFC-5E8A-43B1-8484-02207DCFAE9E

P356

Q36453616-3D6B53E1-486A-45A5-9C70-1C234AA68DD1

P407

Q36453616-86C8C8F9-24F8-489B-854A-70575CEF2D9B

P433

Q36453616-4C824779-F102-4BF5-A002-53162761C3F6

P478

Q36453616-BF6A978B-B4D7-4A4F-A635-E1182C15471A

P577

Q36453616-CEE3BF7A-AA48-4707-A0DD-B50D09C659A0

P5875

Q36453616-854735E7-6D67-4215-BCF5-7458D53FDB12

P698

Q36453616-7811C0A4-F0EE-40B3-A429-E1F6EA4BA169

P921

Q36453616-47F026C8-7E9F-430D-93D5-B236A744C1EF

P932

Q36453616-58B78A15-3185-41E0-9F5C-4F7086215ECC

P356

P1433

P1476

Sodium cromoglycate and ipratropium bromide in exercise-induced asthma

@en

P2093

Kerr JW

http://www.w3.org/2001/XMLSchema#string

Patel KR

http://www.w3.org/2001/XMLSchema#string

Thomson NC

http://www.w3.org/2001/XMLSchema#string

P2860

Normal standards for ventilatory function using an automated wedge spirometer.

Site of airway obstruction in asthma as determined by measuring maximal expiratory flow breathing air and a helium-oxygen mixture.

Immunological release of histamine and slow reacting substance of anaphylaxis from human lung.

Relative contributions of large and small airways to flow limitation in normal subjects before and after atropine and isoproterenol.

The effect of Sch 1000 and disodium cromoglycate on exercise-induced asthma.

Predominant site of flow limitation and mechanisms of postexertional asthma.

The autonomic nervous system and breathing.

Inhibition of exercise-induced asthma by different pharmacological pathways.

The role of the parasymphathetic nervous system in airways disease.

The influence of clinical factors on site of airway obstruction in asthma.

P304

694-699

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THX.33.6.694

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

1978-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

22980374

http://www.w3.org/2001/XMLSchema#string

P698

154747

http://www.w3.org/2001/XMLSchema#string

P921

P932

470965

http://www.w3.org/2001/XMLSchema#string